2024 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2023 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2022 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2021 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2020 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2019 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2017 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2016 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2015 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2014 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications

2013 Louisiana Revised Statutes 22:999.1 – Parity for orally administered anti-cancer medications with intravenously administered or injected anti-cancer medications